Kevin Lee
Board Member
Bicycle Therapeutics PLC (BCYC)Equibles does not estimate personal net worth.
Get an email with a short summary when Bicycle Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get BCYC alertsAbout Kevin Lee
Kevin Lee is recorded as CEO and Board Member at Bicycle Therapeutics PLC (BCYC). The newest filing on record that lists Kevin Lee as CEO at Bicycle Therapeutics PLC (BCYC) is dated April 30, 2021. The newest filing on record that lists Kevin Lee as Board Member at Bicycle Therapeutics PLC (BCYC) is dated April 27, 2020. The proxy statement of Bicycle Therapeutics PLC reports total compensation of $4,376,296 for Kevin Lee in fiscal 2019, including a base salary of $516,950. Disclosed compensation is on record for 2 fiscal years. Bicycle Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Bicycle Therapeutics PLC includes Felix J. Baker, Ph.D. (Chairman and Board Member), Pierre Legault (Chairman), Alethia Young (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2021
-
Current
Start not stated–present
Last confirmed April 27, 2020
Company network
Leadership on record at Bicycle Therapeutics PLC
- Felix J. Baker, Ph.D. Chairman, Board Member
- Pierre Legault Chairman
- Alethia Young CFO
- Travis Thompson CFO, Chief Accounting Officer
- Alistair Milnes COO
- Jennifer Perry COO
- Jennifer Perry, Pharm.D. COO
- Michael Skynner COO, CTO
- Alessandro Riva, M.D. Board Member
- Bosun Hau Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Bicycle Therapeutics PLC (BCYC) | Ph.D., MBA Chief Executive Officer | $516,950 | $4,376,296 |
| 2018 | Bicycle Therapeutics PLC (BCYC) | Ph.D., MBA Chief Executive Officer | $385,549 | $817,894 |
Recent activity
No call appearances or filed executive changes recorded yet.